ClinicalTrials.Veeva

Menu

MOSTEGRA TRIAL:MO-(Dified) STE-(nt) GRA(-ft): Surgeon-modified Fenestrated-branched Stent-grafts

Northside Hospital, Inc. logo

Northside Hospital, Inc.

Status

Terminated

Conditions

Complex Aortic Aneurysms

Treatments

Device: surgeon-modified fenestrated-branched stent-grafts (sm-FBSG)

Study type

Interventional

Funder types

Other

Identifiers

NCT02101463
NSH 997

Details and patient eligibility

About

This trial evaluates surgeon-modified fenestrated-branched stent-grafts (sm-FBSG) for Abdominal Aortic Aneurysms (AAA) that are custom-made intra-operatively with no waiting period by a qualified vascular surgeon. In addition, it aims to examine the alternative sm-FBSG for patients with restricted access to centers performing clinical trials with commercially available devices and those patients with aortic emergencies.

Full description

Complex aortic aneurysms are those involving the renal and visceral arteries, and open repair of these aneurysms requires more extensive dissection, aortic clamping above the renal or mesenteric arteries, and possible reconstruction of aortic branches. Recovery time tends to be longer, including more hospital days, than for endovascular repair, and there is a greater potential for complications. Many high-risk patients with aneurysms of the abdominal aorta (AAA), including thoracoabdominal aortic aneurysms (TAAA), and significant co-morbidities will be denied elective open surgery because of heightened risks associated with open repair of complex aneurysms, and therefore, the potential benefit of an endovascular option increases as well.

Endovascular aneurysm repair has been shown to be an effective alternative in treating uncomplicated infrarenal and thoracic aneurysms in both the elective and urgent setting, yet there is limited experience with this technology in complex conditions. Fenestrated grafts have been developed as a minimally invasive treatment for patients with complex aortic aneurysms who are unfit for traditional open surgery.

Surgeon-modified fenestrated-branch stent grafts (sm-FBSG) with branches for the visceral vessels are custom-made by a qualified vascular surgeon for patients with complex aortic conditions. It is expected that they will minimize surgical risks and promote quicker recovery, and they could represent a therapeutic option for high-risk patients unfit for open surgery.

Enrollment

26 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria (abbreviated):

  • Patients presenting for elective or urgent repair of a complex aortic aneurysm
  • No other investigational agents or devices while on protocol
  • Patient must be able and willing to comply with all follow-up exams
  • Life expectancy of more than 1 year
  • Patients with medical conditions that would make them unfit for open repair

Exclusion Criteria (abbreviated):

  • Estimated life expectancy <1 year
  • Contraindication to angiography
  • Active infection
  • Patients with ruptured or contained ruptured aortic aneurysm who are persistently hemodynamically unstable at the time of presentation
  • Morbid Obesity with inability to visualize the aorta with available intraoperative imaging techniques

Anatomic exclusion criteria: iliac arteries and aorta must be able to accommodate endovascular devices and procedure

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

26 participants in 1 patient group

surgeon-modified fenestrated-branched stent-grafts (sm-FBSG)
Other group
Treatment:
Device: surgeon-modified fenestrated-branched stent-grafts (sm-FBSG)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems